PARADIGM REAL-TIME REVEL SYSTEM

Sensor, Glucose, Invasive

FDA Premarket Approval P150019

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the paradigm real-time revel system. This device is indicated for:paradigm real-time revel insulin pump. The paradigm real-time revel insulin pumps (mmt-523/mmt-723) are indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The paradigm real-time revel system consists of the paradigm mmt-523/mmt-723 insulin pumps, the enlite glucose sensor (mmt-7008), and the minilink transmitter (mmt-7703). Use of the paradigm mmt-523/mmt-723 insulin pumps with the optional sensor and transmitter components is indicated for continuous or periodic monitoring of glucose levels in the fluid under the skin, and possible low and high blood glucose episodes in adults (ages 18 and older). Enlite sensor: the enlite sensor (mmt-7008) is intended for use with the paradigm real-time revel insulin pump systems (mmt-523/mmt-723) to continuously monitor glucose levels in persons with diabetes. Glucose values provided by the paradigm real-time revel system are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on the sensor glucose readings provided by the paradigm real-time revel system.

DevicePARADIGM REAL-TIME REVEL SYSTEM
Classification NameSensor, Glucose, Invasive
Generic NameSensor, Glucose, Invasive
ApplicantMEDTRONIC MINIMED
Date Received2015-06-10
Decision Date2015-12-07
Notice Date2015-12-22
PMAP150019
SupplementS
Product CodeMDS
Docket Number15M-4728
Advisory CommitteeClinical Chemistry
Expedited ReviewNo
Combination Product No
Applicant Address MEDTRONIC MINIMED 18000 Devonshire St northridge, CA 91325
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150019Original Filing
S065 2022-04-01 30-day Notice
S064 2021-11-17 Special (immediate Track)
S063 2021-01-27 Special (immediate Track)
S062 2020-11-03 30-day Notice
S061 2019-11-29 30-day Notice
S060 2019-10-17 30-day Notice
S059
S058 2019-08-21 30-day Notice
S057 2019-07-15 30-day Notice
S056 2019-06-19 30-day Notice
S055
S054 2019-02-11 30-day Notice
S053 2019-02-01 30-day Notice
S052 2018-11-07 30-day Notice
S051 2018-11-07 30-day Notice
S050 2018-11-07 30-day Notice
S049 2018-11-02 30-day Notice
S048 2018-10-15 30-day Notice
S047 2018-10-01 30-day Notice
S046 2018-07-16 30-day Notice
S045 2018-07-09 30-day Notice
S044 2018-06-19 30-day Notice
S043 2018-06-07 Special (immediate Track)
S042 2018-04-30 30-day Notice
S041 2018-03-26 30-day Notice
S040 2018-03-12 30-day Notice
S039 2018-02-09 Real-time Process
S038 2018-02-07 30-day Notice
S037 2018-01-29 30-day Notice
S036 2018-01-29 30-day Notice
S035 2017-12-22 30-day Notice
S034 2017-12-20 Real-time Process
S033 2017-11-24 30-day Notice
S032 2017-10-30 30-day Notice
S031 2017-07-17 30-day Notice
S030 2017-05-30 30-day Notice
S029 2017-04-10 30-day Notice
S028 2017-03-31 30-day Notice
S027 2016-12-23 Real-time Process
S026 2016-11-28 30-day Notice
S025 2016-11-28 30-day Notice
S024 2016-11-09 Real-time Process
S023 2016-11-02 30-day Notice
S022 2016-09-30 Real-time Process
S021
S020 2016-09-19 30-day Notice
S019
S018 2016-07-26 30-day Notice
S017
S016 2016-06-15 135 Review Track For 30-day Notice
S015
S014 2016-04-27 135 Review Track For 30-day Notice
S013 2016-03-28 30-day Notice
S012 2016-03-25 30-day Notice
S011 2016-03-25 30-day Notice
S010 2016-03-09 30-day Notice
S009 2016-03-07 30-day Notice
S008 2016-02-23 30-day Notice
S007 2016-02-17 Real-time Process
S006 2016-02-17 30-day Notice
S005 2016-02-17 30-day Notice
S004 2016-02-17 30-day Notice
S003 2016-02-17 30-day Notice
S002 2016-02-12 30-day Notice
S001 2016-02-12 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00643169693814 P150019 020
00643169694132 P150019 022
00643169694149 P150019 022
00643169694156 P150019 022
00643169694163 P150019 022
00643169694170 P150019 022
00643169694187 P150019 022
00643169694194 P150019 022
00643169694200 P150019 022
00643169693722 P150019 022
00643169693937 P150019 022
00643169693807 P150019 022
00643169693791 P150019 022
00643169693784 P150019 022
00643169693777 P150019 022
00643169693760 P150019 022
00643169693753 P150019 022
00643169693746 P150019 022
00643169693739 P150019 022
00643169694217 P150019 022
00643169694224 P150019 022
00643169861862 P150019 022
00643169932951 P150019 022
00643169932968 P150019 022
00643169932975 P150019 022
00643169932982 P150019 022
00643169933132 P150019 022
00643169933149 P150019 022
00643169933156 P150019 022
00643169933163 P150019 022
00643169932944 P150019 022
00643169883413 P150019 022
00643169861879 P150019 022
00643169861886 P150019 022
00643169861893 P150019 022
00643169861909 P150019 022
00643169883376 P150019 022
00643169883383 P150019 022
00643169883390 P150019 022
00643169883406 P150019 022
00643169933170 P150019 022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.